Our Research

Biogen Idec is committed to developing innovative treatments for patients with high unmet medical needs. For 30 years, we have been focused on transforming scientific discoveries into advances in human healthcare through the discovery, development and commercialization of our own pioneering products and through strategic alliances. Our hemophilia therapeutic area is focused on the discovery and development of innovative, long-acting therapies to treat hemophilia.